Trial Profile
Pharmacokinetic and pharmacodynamic study of filgotinib (GLPG0634) in Japanese and Caucasian healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Feb 2016
Price :
$35
*
At a glance
- Drugs Filgotinib (Primary)
- Indications Crohn's disease
- Focus Pharmacodynamics; Pharmacokinetics
- 08 Feb 2016 New trial record